Durect Corporation Is A Biopharmaceutical Company Based In Cupertinocaliforniafounded In 1998The Company Focuses On Developing Innovative Therapies For Serious Diseases With High Unmet Medical Needsdurect Is Known For Its Work In Epigenetic Therapiesparticularly Targeting Conditions Like Acute Organ Injury And Cancer The Company S Lead Drug Candidatelarsucosteroldur 928 Is Currently In Phase 2B Clinical Trials For Alcohol Associated Hepatitis And Has Received Fast Track Designation From The Fdaother Key Products Include Posimiran Fda Approved Non Opioid Analgesicperseris For Schizophreniaand Methydur For Attention Deficit Hyperactivity Disorderdurect Also Offers Drug Delivery Technologiessuch As The Saber Platformwhich Supports Partnerships With Other Pharmaceutical And Biotech Companies Durect Actively Collaborates With Various Organizationsincluding Innocoll Pharmaceuticalsto Advance Its Products And Technologiesthe Company Emphasizes Research And Developmentwith Significant Investment In This Area To Drive Its Innovative Pipeline Forward
